Evicenter
MarkdownMedical informationP&T meetings
Barzolvolimab (CDX-0159)

Chronic spontaneous urticaria

Launch
Not announced
Last updated
177 sources

Product information and disease descriptionProduct description

Phase of product development

13 evidence topics · 16 sources

Launch

No evidence found.

Development in other indications: cold urticaria, symptomatic dermographism, atopic dermatitis, prurigo nodularis, and eosinophilic esophagitis
FDA expedited program designations for chronic spontaneous urticaria

No evidence found.